144 related articles for article (PubMed ID: 1287888)
1. Arachidonate transfer between platelets and lipoproteins.
Surya II; Gorter G; Akkerman JW
Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
[TBL] [Abstract][Full Text] [Related]
2. Abnormal platelet functions in a patient with abetalipoproteinemia.
Surya II; Mommersteeg M; Gorter G; Erkelens DW; Akkerman JW
Thromb Haemost; 1991 Mar; 65(3):306-11. PubMed ID: 1904656
[TBL] [Abstract][Full Text] [Related]
3. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma.
Stockschläder M; Scharf RE
Thromb Haemost; 1989 Nov; 62(3):1016-22. PubMed ID: 2512674
[TBL] [Abstract][Full Text] [Related]
4. The modulation by serum albumin of rabbit platelet aggregation in response to exogenous sodium arachidonate.
Dratewka-Kos E; Kindl B; Tinker DO; Hsia JC
Can J Biochem Cell Biol; 1985 Aug; 63(8):792-802. PubMed ID: 3933800
[TBL] [Abstract][Full Text] [Related]
5. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
7. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein inhibits platelet 12-lipoxygenase activity.
Fujimoto Y; Tsunomori M; Muta E; Yamamoto T; Nishida H; Sakuma S; Fujita T
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):355-8. PubMed ID: 7827811
[TBL] [Abstract][Full Text] [Related]
9. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
Rao AK; Willis J; Holmsen H
J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
[TBL] [Abstract][Full Text] [Related]
10. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
11. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
14. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
van Willigen G; Gorter G; Akkerman JW
Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
[TBL] [Abstract][Full Text] [Related]
15. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
[TBL] [Abstract][Full Text] [Related]
17. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
Best LC; Holland TK; Jones PB; Russell RG
Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
[TBL] [Abstract][Full Text] [Related]
18. Influence of heat on platelet biochemistry, structure, and function.
Rao GH; Smith CM; Escolar G; White JG
J Lab Clin Med; 1993 Oct; 122(4):455-64. PubMed ID: 8228561
[TBL] [Abstract][Full Text] [Related]
19. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
[TBL] [Abstract][Full Text] [Related]
20. Platelet-modified lipoprotein induced by thrombin: effect of whole blood and plasma.
Aviram M; Maor I; Rosenblat M; Dankner G; Brook JG
Isr J Med Sci; 1988; 24(4-5):193-200. PubMed ID: 3378876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]